Shown are neutralizing-antibody titers against virus pseudotyped with spike protein from ancestral severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) bearing the D614G mutation, along with ...

Since coronavirus 2019 (COVID-19) vaccines have started to be mass-produced, many developed countries have initiated programs designed to immunize as many people as possible. However, many of the new ...

As a result of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), there has been significant morbidity and mortality among nursing home residents during the coronavirus disease 19 (COVID-19 ...

Panel A shows mutations in the SARS-CoV-2 spike protein in omicron subvariants BA.1, BA.2, BA.2.12.1, BA.4–BA.5, and BA.4.6. BA.4 and BA.5 are grouped together because they have identical spike ...